Literature DB >> 1587919

Carbon monoxide poisoning and myocardial ischemia in patients with burns.

J Williams1, R W Lewis, G P Kealey.   

Abstract

Carbon monoxide poisoning is a well-known problem in patients with burns. A retrospective 11-year chart review was undertaken to determine the incidence of myocardial injury after carbon monoxide poisoning. Of the 1533 consecutive admissions from July 1, 1979 to June 30, 1990, 18 patients had carboxyhemoglobin levels of greater than or equal to 10% on admission. Five of these patients were found to have electrocardiographic changes that were indicative of myocardial injury. (Three also had elevated levels of creative kinase-MB). Four of five patients with electrocardiographic changes were operated on successfully with the use of perioperative invasive monitoring. None of the 18 patients had congestive heart failure or cardiac dysrhythmias during their hospital course. These data suggest that myocardial damage can result from acute carbon monoxide poisoning, and appropriate screening is indicated for the detection of such injuries.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587919     DOI: 10.1097/00004630-199203000-00006

Source DB:  PubMed          Journal:  J Burn Care Rehabil        ISSN: 0273-8481


  3 in total

1.  Cardiovascular dysfunction in burns: review of the literature.

Authors:  G S Abu-Sittah; K A Sarhane; S A Dibo; A Ibrahim
Journal:  Ann Burns Fire Disasters       Date:  2012-03-31

2.  Burn mortality in patients with preexisting cardiovascular disease.

Authors:  Laquanda Knowlin; Trista Reid; Felicia Williams; Bruce Cairns; Anthony Charles
Journal:  Burns       Date:  2017-02-08       Impact factor: 2.744

3.  Demographic and clinical characteristics of carbon monoxide poisoning: nationwide data between 1999 and 2012 in Taiwan.

Authors:  Chien-Cheng Huang; Chung-Han Ho; Yi-Chen Chen; Hung-Jung Lin; Chien-Chin Hsu; Jhi-Joung Wang; Shih-Bin Su; How-Ran Guo
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-07-14       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.